The Effects of Sleep on Human Microbiota: Implications for Health and Disease

ConditionSleep
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

The aggregate of microorganisms inhabiting the human body can be regarded as a dynamic reflector of both healthy and disease states, altering in response to changes in the environment. This may precede clinically detectable disease; and thereby, could be used to predict disease onset and additionally monitor response to treatment and predict prognosis. The primary hypothesis of this pilot study is that the human microbial communities are influenced by sleep and altered in humans with abnormal sleep patterns, and they may ultimately relate to disease risk.

Eligibility criteria

Qualifiers

Only subjects who are eligible for ongoing IRB-approved studies will be deemed eligible for this protocol.

Disqualifiers

Pregnant or breast-feeding women

Subjects who are ineligible for ongoing IRB-approved studies will not be included in this protocol

Trial design

Treatments tested in this trial

  • Sleep restriction
  • Weight gain

Treatment groups

5,000 Participants
are divided into 3 treatment groups

Sponsors and collaborators